Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 12, 2012, Pages 1454-1459

  Tjellström, Bo ^a,b   Högberg, Lotta ^b,c   Stenhammar, Lars ^b,c   Magnusson, Karl Eric ^c   Midtvedt, Tore ^a   Norin, Elisabeth ^a   Sundqvist, Tommy ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Norrkoping Hospital   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Children; Crohn's disease; Exclusive enteral nutrition; Fecal short chain fatty acids; Gut microflora

Indexed keywords

ACETIC ACID; ALBUMIN; BUTYRIC ACID DERIVATIVE; C REACTIVE PROTEIN; HEMOGLOBIN; ISOBUTYRIC ACID; OROSOMUCOID; PROPIONIC ACID; SHORT CHAIN FATTY ACID; VALERIC ACID;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERIC FEEDING; ERYTHROCYTE VOLUME; EXCLUSIVE ENTERAL NUTRITION; FECES ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; INTESTINE FUNCTION; LEUKOCYTE; MALE; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE; TREATMENT DURATION;

ACETIC ACID; ADOLESCENT; ANUS DISEASES; BUTYRIC ACID; CASE-CONTROL STUDIES; CHILD; COLITIS; CROHN DISEASE; ENTERAL NUTRITION; FATTY ACIDS, VOLATILE; FECES; FEMALE; FOOD, FORMULATED; GASTROINTESTINAL TRACT; HUMANS; ILEITIS; MALE; METAGENOME; PENTANOIC ACIDS; PROPIONATES; STATISTICS, NONPARAMETRIC;

EID: 84869992194     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.703234     Document Type: Article

References (31)

1. Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB. Inflammatory bowel disease. Arch Dis Child 2006;91:426-32. (Pubitemid 43672374)
2. Ballal SA, Gallini CA, Segata N, Huttenhower C, Garrett WS. Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts. Cell Microbiol 2011;13:508-17.
3. Critch J, Day AS, Otley A, King-Moore C, Teitelbaum JE, Shashidhar H. Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2012;54:298-305.
4. Fell JME. Update of the management of inflammatory bowel disease. Arch Dis Child 2012;97:78-83.
5. Day AS, Whitten KE, Sidler M, Lemberg DA. Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 2008;27:293-307.
6. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Q Annu Rev Nutr 2002;22:283-307. (Pubitemid 35221463)
7. Furrie E. A molecular revolution in the study of intestinal microflora. Gut 2006;55:141-3. (Pubitemid 43117264)
8. Barclay AR, Morrison DJ, Weaver LT. What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? Probing for answers with stable isotopes. J Pediatr Gastroenterol Nutr 2008;46:486-95.
9. Loonen HJ, Griffiths AM, Merkus MP, Derkx HHF. A critical assessment of items on the pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 2003;36:90-5. (Pubitemid 41672625)
10. Midtvedt T, Björneklett A, Carlstedt-Duke B, Gustafsson BE, HöverstadT,LingaasE,et al.Theinfluenceof antibioticsupon microflora associated characteristics in man and animals. In Wostman BS, editor. Germfree research; microflora control and its application to the biochemical sciences. Progress in clinical and biological Research. Vol. 181. New York: Alan R. Liss Corporation, Inc;1985. 241-4.
11. Zijlstra JB, Beukema J, Wothers BG, Byrne BM, Groen A, Dankert J. Pretreatment methods prior to gas chromatographic analysis of volatile fatty acids from fecal samples. Clin Chem Acta 1977;78:243-50. (Pubitemid 8137754)
12. Höverstad T, Björneklett A. Short-chain fatty acids and bowel functions in man. Scand J Gastroenterol 1984;19:1059-65. (Pubitemid 15191077)
13. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemiattractant receptor GPR43. Nature 2009;461:1282-6.
14. Sanderson IR, Croft NM. The anti-inflammatory effects of enteral nutrition. JPEN J Parenter Enteral Nutr 2005;29: S134-40.
15. Sanderson IR. Short chain fatty acid regulation of signalling genes expressed by intestinal epithelium J Nutr. 2004;134:2450S-4S. (Pubitemid 39201620)
16. Banerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, SavageMO,et al. Anti-inflammatory and growthstimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-5.
17. Tedelind S, Westberg F, Kjerrulf M, Vidal A. Antiinflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007;13:2826-32. (Pubitemid 47007897)
18. Di Sabatino A, Morera R, Ciccocioppo R, Cazzola P, Gotti S, Tinozzi FP, et al. Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther 2005;22:789-94. (Pubitemid 41564358)
19. Kovarik JJ, Tillinger W, Hofer J, Hölzl MA, Heinzl H, Saemann MD, et al. Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD. Eur J Clin Invest 2011;41:291-8.
20. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 2010;1801:1175-83.
21. Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil 2012;doi:10.1111/j.1365- 2982.2012.01906.x.
22. Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, et al. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005;29:S173-8.
23. Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment Pharmacol Ther 2008;28:724-33.
24. Dziechciarz P, Horvath A, Shamir R, Szajewska H. Metaanalysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007;26:795-806. (Pubitemid 47346708)
25. Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. Acta Paediatr 2004;91:327-35. (Pubitemid 38316554)
26. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000;31:8-15. (Pubitemid 30456568)
27. Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006;55:356-61. (Pubitemid 43268273)
28. Dethlefsen L, Relman DA. Microbes and health sackler colloquium: incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2010;108:4554-61.
29. Afzal NA, Davies S, Paintin M, Arnaud-Battandier FA, Walker-Smith JA, Murch S, et al. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 2005;50:1471-5. (Pubitemid 41039196)
30. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-54.
31. Dray X, Marteau PM. The use of enteral nutrition in the management of Crohn's disease in adults. JPEN J Parenter Enteral Nutr 2005;29:S166-72.